Search for content, post, videos

LINK Medical and Ectin Research sign agreement

Ola Gudmundsen
LINK Medical and Ectin Research have signed an agreement appointing LINK Medical Research to run the Phase I/II clinical study of the treatment of metastatic bladder cancer patients with the drug candidate MFA-370. Ectin Research aims to submit its clinical trial application (CTA) to the Swedish
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.